InvestorsHub Logo

BonelessCat

01/28/13 9:55 AM

#22433 RE: eddiebali #22427

I like this one:
Kevetrin is a drug that the Company believes will be effective against more than 50 percent of all cancers due to its reactivation of p53. The Company believes that no other anti-cancer drug has shown the ability to activate both transcription-dependent and transcription-independent pathways to promote apoptosis through p53 activation in tumor cells while being non-genotoxic.

MinnieM

01/28/13 10:09 AM

#22437 RE: eddiebali #22427

CTIX - Here's the FDA website for the ongoing phase I trial at Dana Farber: Clinical trials: http://clinicaltrials.gov/ct2/show/nct01664000?term=kevetrin+rank=1